Declining Reimbursements Send Cancer Testing Co. To Ch. 11

A cancer diagnostic testing firm hit Chapter 11 on Wednesday in Delaware with more than $40 million in liabilities after a decrease in insurance reimbursements ate into its profits, while its...

Already a subscriber? Click here to view full article